Vitamin D and Omega-3s Impact on Chronic Disease Prevention

Vitamin D and Omega-3s Impact on Chronic Disease Prevention

JoAnn E. Manson, MD DrPH, Principal Investigator, VITAL Main Study and Chief, Division of Preventive Medicine at Brigham and Women’s Hospital describes the goals of the vitamin D and omega-3 Trial (VITAL)trial. VITAL is a randomized, double-blind, placebo-controlled trial in 26,000 participants investigating whether taking daily dietary supplements of vitamin D (about 2000 IU) or fish oil (about 1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people without a prior history of these illnesses.

Secondary goals of the VITAL trial include study of the role of vitamin D and omega-3s in improving cognitive function, preventing diabetes and reducing the risk of developing insulin resistance or glucose intolerance, and autoimmune diseases such as lupus. 

Learn more at http://www.vitalstudy.org

Read the video transcript about the VITAL clinical trial and the impact of vitamin D and omega-3s on chronic disease prevention.

Presenter

JoAnn E. Manson, MD, DrPHJoAnn E. Manson, MD, DrPH


View Full Video Close Window